Determination of a Metolazone metabolite in human urine by high-performance liquid chromatography/diode-array detection, high-performance liquid chromatography/electrospray ionization mass spectrometry and gas chromatography/mass spectrometry [2]

Rapid Communications in Mass Spectrometry

Volumn 18, Issue 8, 2004, Pages 917-922

  Kim, Yunje ^a   Kim, Sungil ^a   Kim, Myungsoo ^a   Lee, Won ^b  

^a Korea Institute of Science and Technology   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GAS CHROMATOGRAPHY; IONIZATION OF GASES; MASS SPECTROMETRY; METABOLITES;

GASCHROMATOGRAPHY-MASS SPECTROMETRY; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-DIODE ARRAY DETECTIONS; HUMAN URINE; LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION-MASS SPECTROMETRIES;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

DRUG METABOLITE; METOLAZONE;

DIODE; DRUG DETERMINATION; DRUG STRUCTURE; DRUG URINE LEVEL; ELECTROSPRAY MASS SPECTROMETRY; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LETTER; TABLET; URINALYSIS;

EID: 1942438562     PISSN: 09514198     EISSN: None     Source Type: Journal    
DOI: 10.1002/rcm.1398     Document Type: Letter

References (19)

1. Bridges JW, Chasseaud LF. Progress in Drug Metabolism, vol. 7, John Wiley: New York, 1983; 58-171.
2. Weiner IM, Gilman A, Rall TW, Nies AS, Taylor P (eds). Goodman and Gilman's Pharmacological Basis of Therapeutics, Pergamon Press: New York, 1990; 708.
3. Dirks JH, Sutton RAL (eds). Diuretics, Physiology, Pharmacology and Clinical Use, W. B. Saunders Co.: Philadelphia, PA, 1986.
4. Ventura R, Segura J. J. Chromatogr. B 1996; 687: 127.
5. International Olympic Committee, Medical commission, International Olympic Charter Against Doping in Sport, IOC: Lausanne, 1990.
6. Kawasaki K, Fukiyama K. Xenobiotica 1981; 11: 197.
7. Schänzer W. The Problems of Diuretics in Doping Control. Institut für Biochemie der Deutschen Sporthochschule: Köln, 1988, 1, private communication.
8. Puschett JN, Rastegar A. Clin. Pharmacol. Ther. 1974; 15: 397.
9. Hadzija BW, Mattocks AM. J. Chromatogr. 1982; 229: 425.
10. Fleuren HLJM, Van Rossum JM. J. Chromatogr. 1978; 152: 41.
11. Vandenheuvel WJA, Gruber VF, Walker RW, Wolf WJ. J. Pharm. Sci. 1975; 64: 1309.
12. Swart KJ, Botha H. J. Chromatogr. 1987; 413: 315.
13. Hessey GA II, Constanzer ML, Bayne WF. J. Chromatogr. 1986; 380: 450.
14. Sherry JH, O'Donnell JP, Colby HD. J. Chromatogr. 1986; 374: 183.
15. Snedden W, Sharma JN, Fernandez PG. Ther. Drug Monit. 1982; 4: 381.
16. Rapaka RS, Roth J, Viswanathan C, Goehl TJ, Prasad VK, Cabana BE. J. Chromatogr. 1982; 227: 463.
17. McCue BA, Cason MM, Curtis MA, Faulkner RD, Dahlin DC. J. Pharm. Biomed. Anal. 2002; 28: 199.
18. Lindstrom B. J. Chromatogr. 1974; 100: 189.
19. Pfleger K, Maurer HH, Weber A. Mass Spectral Data and GC Data of Drugs, Poisons, Pesticides, Pollutants and Their Metabolites (2nd edn). Wiley-VCH: Weinheim, New York, Basel, Cambridge, 1992: 1831.